Swiss pharma’s big bet on Slovenia
Pharmaceutical giant Novartis invested billions in Slovenia, helping turn the country into a global player in generic drug production. Now, as cheap Asian competitors increasingly dominate the market, Swiss drug companies see the tiny Balkan nation playing a key role in their shift to more complex, expensive medicines. Polonca Kuhar’s career in Slovenia’s pharmaceutical industry
READ MORE